Vemurafenib Market, Global Outlook and Forecast 2022-2028

May 2022 | 74 pages | ID: VBACEDADC8CFEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Vemurafenib in global, including the following market information:

Global Vemurafenib Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Vemurafenib Market Sales, 2017-2022, 2023-2028, (Tons)

Global top five Vemurafenib companies in 2021 (%)

The global Vemurafenib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Purity ?99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vemurafenib include Fermion, Roche, Haohong Biotechnology, LGM Pharma, KeChow Pharma, Hetero, ANQING CHICO, Shanghai Shenyue Biotechnology and Kaiyu Pharmatech. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vemurafenib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vemurafenib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Vemurafenib Market Segment Percentages, by Type, 2021 (%)

• Purity ?99%
• Purity ?99.5%

Global Vemurafenib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Vemurafenib Market Segment Percentages, by Application, 2021 (%)

• Pharmaceutical
• Research Reagents
• Other

Global Vemurafenib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Vemurafenib Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vemurafenib revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Vemurafenib revenues share in global market, 2021 (%)

Key companies Vemurafenib sales in global market, 2017-2022 (Estimated), (Tons)

Key companies Vemurafenib sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Fermion
• Roche
• Haohong Biotechnology
• LGM Pharma
• KeChow Pharma
• Hetero
• ANQING CHICO
• Shanghai Shenyue Biotechnology
• Kaiyu Pharmatech

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Vemurafenib Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Vemurafenib Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VEMURAFENIB OVERALL MARKET SIZE

2.1 Global Vemurafenib Market Size: 2021 VS 2028
2.2 Global Vemurafenib Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Vemurafenib Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Vemurafenib Players in Global Market
3.2 Top Global Vemurafenib Companies Ranked by Revenue
3.3 Global Vemurafenib Revenue by Companies
3.4 Global Vemurafenib Sales by Companies
3.5 Global Vemurafenib Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Vemurafenib Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Vemurafenib Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vemurafenib Players in Global Market
  3.8.1 List of Global Tier 1 Vemurafenib Companies
  3.8.2 List of Global Tier 2 and Tier 3 Vemurafenib Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Vemurafenib Market Size Markets, 2021 & 2028
  4.1.2 Purity ?99%
  4.1.3 Purity ?99.5%
4.2 By Type - Global Vemurafenib Revenue & Forecasts
  4.2.1 By Type - Global Vemurafenib Revenue, 2017-2022
  4.2.2 By Type - Global Vemurafenib Revenue, 2023-2028
  4.2.3 By Type - Global Vemurafenib Revenue Market Share, 2017-2028
4.3 By Type - Global Vemurafenib Sales & Forecasts
  4.3.1 By Type - Global Vemurafenib Sales, 2017-2022
  4.3.2 By Type - Global Vemurafenib Sales, 2023-2028
  4.3.3 By Type - Global Vemurafenib Sales Market Share, 2017-2028
4.4 By Type - Global Vemurafenib Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Vemurafenib Market Size, 2021 & 2028
  5.1.2 Pharmaceutical
  5.1.3 Research Reagents
  5.1.4 Other
5.2 By Application - Global Vemurafenib Revenue & Forecasts
  5.2.1 By Application - Global Vemurafenib Revenue, 2017-2022
  5.2.2 By Application - Global Vemurafenib Revenue, 2023-2028
  5.2.3 By Application - Global Vemurafenib Revenue Market Share, 2017-2028
5.3 By Application - Global Vemurafenib Sales & Forecasts
  5.3.1 By Application - Global Vemurafenib Sales, 2017-2022
  5.3.2 By Application - Global Vemurafenib Sales, 2023-2028
  5.3.3 By Application - Global Vemurafenib Sales Market Share, 2017-2028
5.4 By Application - Global Vemurafenib Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Vemurafenib Market Size, 2021 & 2028
6.2 By Region - Global Vemurafenib Revenue & Forecasts
  6.2.1 By Region - Global Vemurafenib Revenue, 2017-2022
  6.2.2 By Region - Global Vemurafenib Revenue, 2023-2028
  6.2.3 By Region - Global Vemurafenib Revenue Market Share, 2017-2028
6.3 By Region - Global Vemurafenib Sales & Forecasts
  6.3.1 By Region - Global Vemurafenib Sales, 2017-2022
  6.3.2 By Region - Global Vemurafenib Sales, 2023-2028
  6.3.3 By Region - Global Vemurafenib Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Vemurafenib Revenue, 2017-2028
  6.4.2 By Country - North America Vemurafenib Sales, 2017-2028
  6.4.3 US Vemurafenib Market Size, 2017-2028
  6.4.4 Canada Vemurafenib Market Size, 2017-2028
  6.4.5 Mexico Vemurafenib Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Vemurafenib Revenue, 2017-2028
  6.5.2 By Country - Europe Vemurafenib Sales, 2017-2028
  6.5.3 Germany Vemurafenib Market Size, 2017-2028
  6.5.4 France Vemurafenib Market Size, 2017-2028
  6.5.5 U.K. Vemurafenib Market Size, 2017-2028
  6.5.6 Italy Vemurafenib Market Size, 2017-2028
  6.5.7 Russia Vemurafenib Market Size, 2017-2028
  6.5.8 Nordic Countries Vemurafenib Market Size, 2017-2028
  6.5.9 Benelux Vemurafenib Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Vemurafenib Revenue, 2017-2028
  6.6.2 By Region - Asia Vemurafenib Sales, 2017-2028
  6.6.3 China Vemurafenib Market Size, 2017-2028
  6.6.4 Japan Vemurafenib Market Size, 2017-2028
  6.6.5 South Korea Vemurafenib Market Size, 2017-2028
  6.6.6 Southeast Asia Vemurafenib Market Size, 2017-2028
  6.6.7 India Vemurafenib Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Vemurafenib Revenue, 2017-2028
  6.7.2 By Country - South America Vemurafenib Sales, 2017-2028
  6.7.3 Brazil Vemurafenib Market Size, 2017-2028
  6.7.4 Argentina Vemurafenib Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Vemurafenib Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Vemurafenib Sales, 2017-2028
  6.8.3 Turkey Vemurafenib Market Size, 2017-2028
  6.8.4 Israel Vemurafenib Market Size, 2017-2028
  6.8.5 Saudi Arabia Vemurafenib Market Size, 2017-2028
  6.8.6 UAE Vemurafenib Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Fermion
  7.1.1 Fermion Corporate Summary
  7.1.2 Fermion Business Overview
  7.1.3 Fermion Vemurafenib Major Product Offerings
  7.1.4 Fermion Vemurafenib Sales and Revenue in Global (2017-2022)
  7.1.5 Fermion Key News
7.2 Roche
  7.2.1 Roche Corporate Summary
  7.2.2 Roche Business Overview
  7.2.3 Roche Vemurafenib Major Product Offerings
  7.2.4 Roche Vemurafenib Sales and Revenue in Global (2017-2022)
  7.2.5 Roche Key News
7.3 Haohong Biotechnology
  7.3.1 Haohong Biotechnology Corporate Summary
  7.3.2 Haohong Biotechnology Business Overview
  7.3.3 Haohong Biotechnology Vemurafenib Major Product Offerings
  7.3.4 Haohong Biotechnology Vemurafenib Sales and Revenue in Global (2017-2022)
  7.3.5 Haohong Biotechnology Key News
7.4 LGM Pharma
  7.4.1 LGM Pharma Corporate Summary
  7.4.2 LGM Pharma Business Overview
  7.4.3 LGM Pharma Vemurafenib Major Product Offerings
  7.4.4 LGM Pharma Vemurafenib Sales and Revenue in Global (2017-2022)
  7.4.5 LGM Pharma Key News
7.5 KeChow Pharma
  7.5.1 KeChow Pharma Corporate Summary
  7.5.2 KeChow Pharma Business Overview
  7.5.3 KeChow Pharma Vemurafenib Major Product Offerings
  7.5.4 KeChow Pharma Vemurafenib Sales and Revenue in Global (2017-2022)
  7.5.5 KeChow Pharma Key News
7.6 Hetero
  7.6.1 Hetero Corporate Summary
  7.6.2 Hetero Business Overview
  7.6.3 Hetero Vemurafenib Major Product Offerings
  7.6.4 Hetero Vemurafenib Sales and Revenue in Global (2017-2022)
  7.6.5 Hetero Key News
7.7 ANQING CHICO
  7.7.1 ANQING CHICO Corporate Summary
  7.7.2 ANQING CHICO Business Overview
  7.7.3 ANQING CHICO Vemurafenib Major Product Offerings
  7.7.4 ANQING CHICO Vemurafenib Sales and Revenue in Global (2017-2022)
  7.7.5 ANQING CHICO Key News
7.8 Shanghai Shenyue Biotechnology
  7.8.1 Shanghai Shenyue Biotechnology Corporate Summary
  7.8.2 Shanghai Shenyue Biotechnology Business Overview
  7.8.3 Shanghai Shenyue Biotechnology Vemurafenib Major Product Offerings
  7.8.4 Shanghai Shenyue Biotechnology Vemurafenib Sales and Revenue in Global (2017-2022)
  7.8.5 Shanghai Shenyue Biotechnology Key News
7.9 Kaiyu Pharmatech
  7.9.1 Kaiyu Pharmatech Corporate Summary
  7.9.2 Kaiyu Pharmatech Business Overview
  7.9.3 Kaiyu Pharmatech Vemurafenib Major Product Offerings
  7.9.4 Kaiyu Pharmatech Vemurafenib Sales and Revenue in Global (2017-2022)
  7.9.5 Kaiyu Pharmatech Key News

8 GLOBAL VEMURAFENIB PRODUCTION CAPACITY, ANALYSIS

8.1 Global Vemurafenib Production Capacity, 2017-2028
8.2 Vemurafenib Production Capacity of Key Manufacturers in Global Market
8.3 Global Vemurafenib Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 VEMURAFENIB SUPPLY CHAIN ANALYSIS

10.1 Vemurafenib Industry Value Chain
10.2 Vemurafenib Upstream Market
10.3 Vemurafenib Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Vemurafenib Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Vemurafenib in Global Market
Table 2. Top Vemurafenib Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Vemurafenib Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Vemurafenib Revenue Share by Companies, 2017-2022
Table 5. Global Vemurafenib Sales by Companies, (Tons), 2017-2022
Table 6. Global Vemurafenib Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Vemurafenib Price (2017-2022) & (US$/Ton)
Table 8. Global Manufacturers Vemurafenib Product Type
Table 9. List of Global Tier 1 Vemurafenib Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vemurafenib Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Vemurafenib Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Vemurafenib Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Vemurafenib Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Vemurafenib Sales (Tons), 2017-2022
Table 15. By Type - Global Vemurafenib Sales (Tons), 2023-2028
Table 16. By Application – Global Vemurafenib Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Vemurafenib Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Vemurafenib Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Vemurafenib Sales (Tons), 2017-2022
Table 20. By Application - Global Vemurafenib Sales (Tons), 2023-2028
Table 21. By Region – Global Vemurafenib Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Vemurafenib Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Vemurafenib Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Vemurafenib Sales (Tons), 2017-2022
Table 25. By Region - Global Vemurafenib Sales (Tons), 2023-2028
Table 26. By Country - North America Vemurafenib Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Vemurafenib Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Vemurafenib Sales, (Tons), 2017-2022
Table 29. By Country - North America Vemurafenib Sales, (Tons), 2023-2028
Table 30. By Country - Europe Vemurafenib Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Vemurafenib Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Vemurafenib Sales, (Tons), 2017-2022
Table 33. By Country - Europe Vemurafenib Sales, (Tons), 2023-2028
Table 34. By Region - Asia Vemurafenib Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Vemurafenib Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Vemurafenib Sales, (Tons), 2017-2022
Table 37. By Region - Asia Vemurafenib Sales, (Tons), 2023-2028
Table 38. By Country - South America Vemurafenib Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Vemurafenib Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Vemurafenib Sales, (Tons), 2017-2022
Table 41. By Country - South America Vemurafenib Sales, (Tons), 2023-2028
Table 42. By Country - Middle East & Africa Vemurafenib Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Vemurafenib Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Vemurafenib Sales, (Tons), 2017-2022
Table 45. By Country - Middle East & Africa Vemurafenib Sales, (Tons), 2023-2028
Table 46. Fermion Corporate Summary
Table 47. Fermion Vemurafenib Product Offerings
Table 48. Fermion Vemurafenib Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 49. Roche Corporate Summary
Table 50. Roche Vemurafenib Product Offerings
Table 51. Roche Vemurafenib Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 52. Haohong Biotechnology Corporate Summary
Table 53. Haohong Biotechnology Vemurafenib Product Offerings
Table 54. Haohong Biotechnology Vemurafenib Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 55. LGM Pharma Corporate Summary
Table 56. LGM Pharma Vemurafenib Product Offerings
Table 57. LGM Pharma Vemurafenib Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 58. KeChow Pharma Corporate Summary
Table 59. KeChow Pharma Vemurafenib Product Offerings
Table 60. KeChow Pharma Vemurafenib Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 61. Hetero Corporate Summary
Table 62. Hetero Vemurafenib Product Offerings
Table 63. Hetero Vemurafenib Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 64. ANQING CHICO Corporate Summary
Table 65. ANQING CHICO Vemurafenib Product Offerings
Table 66. ANQING CHICO Vemurafenib Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 67. Shanghai Shenyue Biotechnology Corporate Summary
Table 68. Shanghai Shenyue Biotechnology Vemurafenib Product Offerings
Table 69. Shanghai Shenyue Biotechnology Vemurafenib Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 70. Kaiyu Pharmatech Corporate Summary
Table 71. Kaiyu Pharmatech Vemurafenib Product Offerings
Table 72. Kaiyu Pharmatech Vemurafenib Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 73. Vemurafenib Production Capacity (Tons) of Key Manufacturers in Global Market, 2020-2022 (Tons)
Table 74. Global Vemurafenib Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Vemurafenib Production by Region, 2017-2022 (Tons)
Table 76. Global Vemurafenib Production by Region, 2023-2028 (Tons)
Table 77. Vemurafenib Market Opportunities & Trends in Global Market
Table 78. Vemurafenib Market Drivers in Global Market
Table 79. Vemurafenib Market Restraints in Global Market
Table 80. Vemurafenib Raw Materials
Table 81. Vemurafenib Raw Materials Suppliers in Global Market
Table 82. Typical Vemurafenib Downstream
Table 83. Vemurafenib Downstream Clients in Global Market
Table 84. Vemurafenib Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Vemurafenib Segment by Type
Figure 2. Vemurafenib Segment by Application
Figure 3. Global Vemurafenib Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Vemurafenib Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Vemurafenib Revenue, 2017-2028 (US$, Mn)
Figure 7. Vemurafenib Sales in Global Market: 2017-2028 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Vemurafenib Revenue in 2021
Figure 9. By Type - Global Vemurafenib Sales Market Share, 2017-2028
Figure 10. By Type - Global Vemurafenib Revenue Market Share, 2017-2028
Figure 11. By Type - Global Vemurafenib Price (US$/Ton), 2017-2028
Figure 12. By Application - Global Vemurafenib Sales Market Share, 2017-2028
Figure 13. By Application - Global Vemurafenib Revenue Market Share, 2017-2028
Figure 14. By Application - Global Vemurafenib Price (US$/Ton), 2017-2028
Figure 15. By Region - Global Vemurafenib Sales Market Share, 2017-2028
Figure 16. By Region - Global Vemurafenib Revenue Market Share, 2017-2028
Figure 17. By Country - North America Vemurafenib Revenue Market Share, 2017-2028
Figure 18. By Country - North America Vemurafenib Sales Market Share, 2017-2028
Figure 19. US Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Vemurafenib Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Vemurafenib Sales Market Share, 2017-2028
Figure 24. Germany Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 25. France Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Vemurafenib Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Vemurafenib Sales Market Share, 2017-2028
Figure 33. China Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 37. India Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Vemurafenib Revenue Market Share, 2017-2028
Figure 39. By Country - South America Vemurafenib Sales Market Share, 2017-2028
Figure 40. Brazil Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Vemurafenib Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Vemurafenib Sales Market Share, 2017-2028
Figure 44. Turkey Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Vemurafenib Revenue, (US$, Mn), 2017-2028
Figure 48. Global Vemurafenib Production Capacity (Tons), 2017-2028
Figure 49. The Percentage of Production Vemurafenib by Region, 2021 VS 2028
Figure 50. Vemurafenib Industry Value Chain
Figure 51. Marketing Channels